Author: Malani, P.N.
Description: In terms of both patient numbers and clinical effect, infections associated with methicillin-resistant Staphylococcus aureus (MRSA) present a significant challenge to clinicians. Serious S aureus infections are associated with high morbidity and mortality, with the acquisition of methicillin resistance further limiting therapeutic options. In recent years, so-called community-acquired MRSA strains (USA300 strain) have proven highly virulent and particularly difficult to control.1 As such, novel approaches to MRSA prevention remain a priority.
Subject headings: Cost of Illness; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections/epidemiology/microbiology
Publication year: 2014
Journal or book title: Jama
Volume: 311
Issue: 14
Pages: 1438-1439
Find the full text :Â https://jamanetwork.com/journals/jama/article-abstract/1857320
Find more like this one (cited by): https://scholar.google.com/scholar?cites=8137349701655377099&as_sdt=1000005&sciodt=0,16&hl=en
Type: Journal Article
Serial number: 1844